Home > Biogen Inc. stock up 40% in a day: here is where to buy it

Biogen Inc. stock up 40% in a day: here is where to buy it

Biogen Inc. (NASDAQ: BIIB) has skyrocketed in value by over 40% in recent days.

This article explains why Biogen Inc. is on the up. We dig into the reasons behind its overnight surge, and we also list the best places to buy Biogen shares should you wish to get involved.

Where to buy Biogen stock today

If you want to buy BIIB stock, your best option is to sign up to a reliable stockbroker. However, not all platforms are equal. We have listed our top two picks below because they provide a strong blend of low fees and a quality interface.

eToro

eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.

Register with eToro instantly

Webull

Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.

Register with Webull instantly

What is Biogen?

Founded in Geneva, Switzerland in 1987, Biogen is now headquartered in Cambridge, Massachusetts.

It is a biotechnology company that claims to specialise in the discovery, development and delivery of therapies for the treatment of neurological diseases for patients all around the globe.

Why is BIIB stock on the rise?

Thanks to the unexpected approval of the company’s controversial Alzheimer’s drug,

surprise Food and Drug Administration approval of its controversial Alzheimer’s disease drug, Aducanumab (brand name: Aduhelm).

The blockbuster drug is the first new Alzheimer’s medication to be approved in 20 years, which is no mean feat.

Should I buy Biogen stock?

If you believe Aducanumab could be commercialised and achieve significant success, Biogen could be a stock to consider closely.

Just be aware that biotechnology companies often carry increased risk due to the fine margins involved in achieving commercial success with a new, sometimes experimental, treatment.

Biogen price prediction

Thanks to this latest surprise, the predictions of most analysts have been blown out of the water. Moreover, following this approval, we would like to see events unfold further before committing to a definitive BIIB price target.

Trade/invest in stocks with just $50
Invest for dividends and get payout on stocks on Ex-Dividend day
Over 11 payment methods, including PayPal
Open my Account

We use cookies to personalise content & ads, provide social media features and offer you a better experience. By continuing to browse the site or clicking "OK, Thanks" you are consenting to the use of cookies on this website.